What is the most effective management for women with recurrent vulvovaginal candidiasis (four or more episodes within one year)?
Prophylaxis with six months of azole therapy (like fluconazole) will result in relapse in 9-19 percent of women compared to 50-64 percent on placebo (one fewer woman would relapse for every 2-4 treated). Efficacy^ however^ declines after therapy cessation and clinical cure remains elusive. Limited evidence suggests women may prefer episodic over maintenance therapy.
Publication Date: 2017-1-23
Last Updated on PCR: 2017-03-22 23:42:52